Clinical Trial Update: Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+) [Phase 2]

View source ↗

Summary

Phase II study evaluating safety and efficacy of imatinib mesylate in children with Philadelphia chromosome-positive chronic myeloid leukemia. The status of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Renato Melaragno | Conditions: Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+) | Phase 2 | Status: UNKNOWN